← Eichor
Study identifier: NCT05218850 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

Condition: Ulcerative Colitis  ·  Sponsor: Children's Hospital Los Angeles

PhasePhase 2
Planned participants10
Who can joinAll sexes, 7 Years to 21 Years
Healthy volunteersNo

About this study

Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.

This description comes directly from the study's public registry record.

Talk to the study team

Sonia Michail, MD  ·  3233611353  ·  sonia.michail@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital Los AngelesLos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05218850